Extension of the technical Memorandum of Understanding between ANSES and the Chinese Institute of Veterinary Drug Control (IVDC)

On November 18 2015, Jean-Pierre Orand, Director of the French Agency for Veterinary Medicinal Products (ANMV), a part of ANSES, and Xuepeng Cai, Director General of the Institute of Veterinary Drug Control (IVDC) of the People's Republic of China, signed an extension of the technical Memorandum of Understanding under which they have been linked since 2010, thus reinforcing their cooperation.

In view of the many areas in which the ANMV and the IVDC have responsibilities in common, particularly in connection with veterinary medicinal drugs, the two agencies started working together five years ago. In November 2010, a Memorandum of Understanding was signed between the two institutions to establish a collaborative partnership and exchange information on the governance of veterinary medicinal drugs.

The partnership between the ANMV and the IVDC has thus been proving its worth since 2010, since when four training sessions have been organised for experts from the IVDC at the ANMV, to two of ANSES's Nancy and Fougères Laboratories both contributed; the ANMV participated in a seminar in China; six training sessions were provided in China by experts from the ANMV; and finally four meetings were held between the Directors, exceptional opportunities for reviewing the actions undertaken and deciding on future initiatives.

The agreement signed today to extend the technical Memorandum of Understanding will strengthen the scientific and technical cooperation between the two bodies, with due respect for the independence of each. The principal aim is to provide expertise in the areas of risk assessment and management for all activities related to veterinary medicinal drugs, such as:

  • assessment of veterinary medicinal chemicals,
  • assessment of vaccines,
  • inspection of establishments producing veterinary pharmaceuticals,
  • pharmacovigilance,
  • monitoring the quality of veterinary medicinal drugs,
  • antimicrobial resistance.